VITEK® MS innovative system reduces the time to detect microbial contaminants from days to minutes, adding a never-before possible level of safety in the production of many consumer goods.
Fast-tracked, simultaneous AOAC OMA approval of two assays marks the significance of this complete Listeria package.
The only CE-marked and FDA-approved BRAF test able to simultaneously detect 2 BRAF mutations, V600E and V600K providing high medical value information to select treatment for metastatic melanoma patients.
As part of our ongoing commitment to process improvement, bioMérieux will be upgrading its logistics and warehouse management systems in the coming months.
bioMérieux, a world leader in the field of in vitro diagnostics, is proud to announce Roberta B. Carey, Ph.D as the 2013 recipient of the bioMérieux Sonnenwirth Award for Leadership in Clinical Microbiology. The award will be given during the 2013 General Meeting of the American Society for Microbiology (ASM) awards dinner in Denver on Sunday, May 19. Given in memory of Alexander Sonnenwirth, Ph.D., the award honors a top microbiologist for her or his innovation in clinical laboratory science, dedication to ASM and leadership in the microbiology field.
bioMérieux Will Feature Presentations Detailing the Revolutionary Potential of MALDI-TOF Mass Spectrometry Technology for Microbial Identification.
Sepsis is Top of Mind for New York Healthcare Providers as Rory’s Regulation, a Law Before New York Legislators Now, Proposes to Mandate All Hospitals Adopt New Protocols for Sepsis Identification and Treatment.
Deep-vein thrombosis (DVT) awareness is key to saving lives from this condition which kills as many as 300,000 people each year in the U.S.
bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review the full-year of 2012.
bioMérieux Opens a Subsidiary in Vietnam, Strengthening its Footprint in High-growth Southeast Asia
